NOVELLI, Francesco

NOVELLI, Francesco  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 100 (tempo di esecuzione: 0.022 secondi).
Titolo Data di pubblicazione Autore(i) File
A Mouse To Human Autoantibody Signature in Pancreatic Ductal Adenocarcinoma 2010 Capello Michela; Cappello Paola; Linty Federica; Scarpa Aldo; Pederzoli Paolo; Nisticò Paola; Milella Michele; Novelli Francesco
A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients. 2011 Simona Rolla; Valentina Bardina; Marinella Clerico; Paola Bonaventura; Pietro Quaglino; Giulia Contessa; Luca Durelli; Francesco Novelli
Abstract 4984: Chemotherapy induces a coordinate autoantibody and T-cell response against tumor-associated antigens in pancreatic cancer patients 2016 Novelli, Francesco; Mandili, Giorgia; Mazza, Emanuela; Bulfamante, Sonia Bulfamante; Giordano, Daniele; Follia, Laura; Cappello, Paola
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth 2015 Capello, Michela; Ferri-Borgogno, Sammy; Principe, Moitza; Chattaragada, Michelle Samuel; Riganti, Chiara; Zhou, Weidong; Follia, Laura; Liotta, Lance A.; Petricoin, Emanuel F.; Cappello, Paola; Novelli, Francesco
Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months 2016 Durelli, L; De Mercanti, S; Rolla, S; Cucci, A; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Annovazzi, P; Horakova, D; Novelli, F; Clerico, M
Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation 2016 Durelli, L; De Mercanti, SF; Cucci, A; Taverna, D; Rolla, S; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Horakova, D; Annovazzi, P; Novelli, F; Clerico, M
Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials 2012 De Mercanti, S.; Cucci, A.; Viglietti,E.; Giai Via,A.; Taverna, D.; Cimino,D.;Rolla, S.; Bardina,V.; Novelli, F.; Vargas,J.; Gibbin,M.; Piazza,F.; Vladic,A.; Brina.V.; Habek,M.; Cocco,E.; Annavazzi,P.; Horakova,D.; Clerico, M.; Durelli, L.
Alpha-enolase elicits specific adenocarcinoma pancreatic-T cell responses in healthy donors and tumor patients 2007 Novelli F; Tomaino B; Ciccarelli M; Capello M; Giovarelli M; Novarino A; Cappello P.
An integrative transcriptomic analysis of glycolytic genes reveals distinct metabolic subtypes in pancreatic cancer 2018 Laura Follia, Giulio Ferrero, Giorgia Mandili, Marco Beccuti, Hiroyuki Katayama, Hong Wang, Amin A. Momin, Michela Capello, Samir M. Hanash, Francesco Novelli, Francesca Cordero
Antibody and T cell response profiling in pancreatic cancer patients before and after chemotherapy identify tumor associated antigens suitable for immunotherapy 2018 Sara Bulfamante, Giorgia Mandili, Moitza Principe, Daniele Giordano, Emanuela Mazza, Claudia Curcio, Laura Follia, Giulio Ferrero, Andrea Evangelista, Maria Antonietta Satolli, Paola Cappello, Francesco Novelli
Antibody and T cell response profiling of pancreatic cancer patients before and after chemotherapy reveals increased recognition of antigens suitable for immunotherapy 2017 Giorgia Mandili, Moitza Principe, Emanuela Mazza, Sara Bulfamante, Laura Follia, Giulio Ferrero, Andrea Evangelista, Daniele Giordano, Paola Cappello, Francesco Novelli
Autoantibodies to the ectoenzyme a enolase, identify a pancreatic adenocarcinoma (PDA)-associated antigen that elicits both CD4 and CD8 T cell response 2006 Cappello P; Tomaino B; Ciccarelli M; Alessio M; Giovarelli M; Novelli F.
can the increase of T-helper 17 Lymphocyte percentage in peripheral blood anticipate a relapse in relapsing remitting multiple sclerosis? 2010 Luca Durelli; Marinella Clerico; Simona Rolla; Giulia Contessa; Stefania De Mercanti; Antoni Uccelli; Mauro Zaffaroni; Paola Cavalla; Luciano Rinaldi; Cristoforo Comi; Roberto Cavallo; Luisa Sosso; Francesco Novelli
CHARACTERIZATION OF AUTOREACTIVE TCR REPERTOIRE IN PATIENTS AFFECTED BYMULTIPLE SCLEROSIS. 2011 Simona Rolla; Gabriele Di Sante; Marinella Clerico; Chiara Nicolò; Agata Katia Patanella; Antonio Amoroso; Maria Edvige Fasano; Anna Paola Batocchi; Francesco Ria; Francesco Novelli
Chemotherapy effects on immune-complexes in pancreatic ductal adenocarcinoma patients serum 2018 Giorgia Mandili, Laura Follia, Giulio Ferrero, Hiroyuki Katayama, Wang Hong, Amin A. Momin, Michela Capello, Francesca Cordero, Samir M. Hanash, Francesco Novelli
Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression 2013 D. Pierobon, MC Bosco , F. Blengio, F. Raggi, A Eva,M. Filippi, T. Musso;F. Novelli, P. Cappello, L. Varesio, M. Giovarelli
Circulating T helper 22 cells increase in multiple sclerosis patients:phenotypical and functional characterization. 2011 Simona Rolla ; Marinella Clerico; Valentina Bardina; Paola Bonaventura; Pietro Quaglino; Giulia Contessa; Luca Durelli; Francesco Novelli
Computational modeling of pancreatic cancer cells metabolism 2015 Niccolò Totis, Chiara Fornari, Laura Follia, Chiara Riganti, Marco Beccuti, Francesco Novelli, Gianfranco Balbo, Francesca Cordero
Dealing with indetermination in biochemical networks 2017 Totis, Niccolò; Beccuti, Marco; Cordero, Francesca; Follia, Laura; Riganti, Chiara; Novelli, Francesco; Balbo, Gianfranco
Dendritic cells transfected with DNA encoding ErbB2 rat/human chimeric plasmids are able to activate in vitro a specific T cell response in ErbB2+ cancer patients 2011 Sergio Occhipinti; Laura Sponton; Cristiana Caorsi; Augusto Amici; Cristina Marchini; Guido Forni; Anna Novarino; Michela Donadio; Libero Ciuffreda; Anna Sapino; Giorgio Inghirami; Francesco Novelli; Mirella Giovarelli